A study to evaluate the efficacy of theracurmin (highly absorbtive curcumin) for cachexia in treatment-resistant cancer patients
Not Applicable
- Conditions
- treatment-resistant cancer patients
- Registration Number
- JPRN-UMIN000014335
- Lead Sponsor
- Institute for Advanced Medical and Science Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who undergo chemotherapy, operation, or radiation 2.Considered inadequate for the inclusion in the study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method immunological effect The expression of cytokines
- Secondary Outcome Measures
Name Time Method At before and 30days,60days, and 90days after the administration of theracurmin 1)Nutrition status 2)QOL score